+49 (0) 6172 608-2485
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
Fresenius is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment.
The Fresenius Group includes four independently operated business segments, each one active in a major growth area of healthcare. Fresenius Medical Care is the world leader in treating people with chronic kidney failure. Fresenius Helios is Europe’s largest private hospital operator. Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services to help critically and chronically ill patients, while Fresenius Vamed plans, develops and manages healthcare facilities.
At Fresenius, the patient always comes first. For more than 100 years now we have been working to save lives and improve the quality of life of our patients.
View this post on Instagram
@freseniuskabi has opened a new state-of-the-art #compounding center in #Canada 🇨🇦. It involves an #investment of 11 million Canadian dollars (more than €7 million) 💰, and the new site expands the company’s presence in #Mississauga, Ontario. Fresenius Kabi is responding to increasing demand for large batches of compounded #medications for patients in Canadian #hospitals 🏥, and the 35,000-square-foot (3,300-square-meter) compounding center has the capacity to expand. The new facility is expected to employ 70 people 👩🔬👨🔬 by 2022.
A post shared by Fresenius (@fresenius.group) on
Fresenius SE & Co. KGaA
61352 Bad Homburg v.d.H.
T +49 (0) 6172 608-0